| Sarah Wynelle Bernhards, FNP-C | |
|
16549 Aurora Ave N, Shoreline, WA 98133-5308 | |
| (206) 788-3757 | |
| Not Available |
| Full Name | Sarah Wynelle Bernhards |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 16549 Aurora Ave N, Shoreline, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629750070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | AP61471480 (Washington) | Primary |
| Entity Name | International Community Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376659151 PECOS PAC ID: 5799695672 Enrollment ID: O20040301000204 |
News Archive
In 2004 the current Ukrainian president, Viktor Yushchenko, suffered a severe case of dioxin poisoning. In order to understand how the human body reacts to remove the poison, Empa researchers have analyzed over a hundred samples taken from the politician.
GlaxoSmithKline today announced that the United States Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted unanimously in support of the approval of VOTRIENT(TM) (pazopanib). Specifically, the panel voted that the benefit-to-risk profile is acceptable for patients with advanced renal cell carcinoma (RCC). Pazopanib is an investigational, oral treatment for patients with advanced RCC.
New research – by scientists at the University of Chicago, Johns Hopkins School of Medicine and the University of Iowa in the USA – describes a novel COVID-19 vaccine candidate that has achieved impressive immunologic results in mouse studies.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Wynelle Bernhards, FNP-C Po Box 3007, Seattle, WA 98114-3007 Ph: (206) 533-2600 | Sarah Wynelle Bernhards, FNP-C 16549 Aurora Ave N, Shoreline, WA 98133-5308 Ph: (206) 788-3757 |
News Archive
In 2004 the current Ukrainian president, Viktor Yushchenko, suffered a severe case of dioxin poisoning. In order to understand how the human body reacts to remove the poison, Empa researchers have analyzed over a hundred samples taken from the politician.
GlaxoSmithKline today announced that the United States Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted unanimously in support of the approval of VOTRIENT(TM) (pazopanib). Specifically, the panel voted that the benefit-to-risk profile is acceptable for patients with advanced renal cell carcinoma (RCC). Pazopanib is an investigational, oral treatment for patients with advanced RCC.
New research – by scientists at the University of Chicago, Johns Hopkins School of Medicine and the University of Iowa in the USA – describes a novel COVID-19 vaccine candidate that has achieved impressive immunologic results in mouse studies.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited received final approval on July 20 from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Minocycline Hydrochloride Extended Release Tablets (Minocycline ER), 45 mg, 90 mg and 135 mg, the generic version of Solodyn® ER, a treatment for acne, sold by Medicis Pharmaceuticals Corporation (Medicis). Mylan Pharmaceuticals Inc. commenced immediate shipment of the product after approval.
› Verified 5 days ago
Ms. Mary Elizabeth Cain, ARNP, MC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1424 Ne 155th St Ste 205, Shoreline, WA 98155 Phone: 206-361-2379 Fax: 206-523-2978 | |
David Zane, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15230 15th Ave Ne, B17-31, Shoreline, WA 98155 Phone: 206-361-3087 Fax: 206-361-5246 | |
Suzanne K Bladek, APRN, BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 355 Nw Richmond Beach Rd, Shoreline, WA 98177 Phone: 206-546-5181 Fax: 206-546-6575 | |
Morgan Lu, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 16549 Aurora Ave N, Shoreline, WA 98133 Phone: 206-533-2600 Fax: 206-962-3299 | |
Amy Braun Boone, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 19521 22nd Ave Nw, Shoreline, WA 98177 Phone: 206-542-7408 | |
Dr. Maya Pilar Isaguirre, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 16628 Meridian Ave N, Shoreline, WA 98133 Phone: 810-618-3572 | |
Kyle Danielson, MPH, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1355 N 205th St, Shoreline, WA 98133 Phone: 206-542-5656 |